Gravi-Tech™ Density Modified Formulations and Versaflex™ TPEs for Cosmetics Packaging Enhance your cosmetic packaging with Gravi-Tech and Versaflex solutions

Gravi-Tech™ Density Modified Formulations and Versaflex™ TPEs for Cosmetics Packaging Enhance your cosmetic packaging with Gravi-Tech and Versaflex solutions

Gravi-Tech™ Density Modified Formulations and Versaflex™ TPEs for Cosmetics Packaging Enhance your cosmetic packaging with Gravi-Tech and Versaflex solutions

No:8 Esenyurt/İstanbul 4 Taahhüt Edilen Sermaye Miktarı 100.799.000,00 TL 5 Ödenen Sermaye Miktarı 100.799.000,00 TL 6 Yönetim Kurulu Üyeleri • Holger Hans Kronimus (Yönetim Kurulu Başkanı) • Christoph Palm (Yönetim Kurulu Başkan Yardımcısı) • Zaneta Gabriela Potoczny (Yönetim Kurulu Üyesi) 7 Bağımsız Denetçi Ticaret Unvanı: Elit Bağımsız Denetim ve Yeminli Mali Müşavirlik Anonim Şirketi Adresi: Halaskargazi Cad. No:8 Esenyurt/İstanbul 4 Committed and Paid Company Capital TRY 100,799,000.00 5 Full names of the Board members of the Company (in the event that a legal entity is a board member, that legal entity's MERSIS number, trade name, registered address and its individual representative's full name) • Holger Hans Kronimus • Christoph Palm • Zaneta Gabriela Potoczny 6 Independent auditor's title, registered address, and branch offices (if any).

PolyOne Corporation Investor Day 2012 PolyOne Investor Presentation 5th Annual Wells Fargo Industrial and Construction Conference May 8, 2014 • In this presentation, statements that are not reported financial results or other historical information are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. You are advised to consult any further disclosures we make on related subjects in our reports on Form 10-Q, 8-K and 10-K that we provide to the Securities and Exchange Commission. ���PolyOne Investor Presentation�5th Annual Wells Fargo�Industrial and Construction Conference �May 8, 2014 �� Forward – Looking Statements Use of Non-GAAP Measures PolyOne Commodity to Specialty Transformation Confirmation of Our Strategy Strategy and Execution Drive Results PolyOne�At A Glance Mix Shift Highlights Specialty Transformation Proof of Performance & 2015 Goals Bridge to $2.50 Adjusted EPS by 2015 Innovation Drives Earnings Growth Unique and Innovative Solutions Debt Maturities & Pension Funding – 3/31/14 Free Cash Flow and Strong Balance Sheet �Fund Investment / Shareholder Return Why Invest In PolyOne?

INVESTOR DAY O R L A N D O , F L O R I D A | M A Y 2 0 1 8 FORWARD LOOKING STATEMENTS PolyOne Corporation 2 In this presentation, statements that are not reported financial results or other historical information are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. You are advised to consult any further disclosures we make on related subjects in our reports on Form 10-Q, 8-K and 10-K that we provide to the Securities and Exchange Commission. I N V E S T O R D A Y A G E N D A M A Y 1 0 , 2 0 1 8 PolyOne Corporation 5 8:00 WELCOME BREAKFAST 9:00 Introduction: Bob Patterson 9:45 Investing for Growth: Michael Garratt Commercial Resources Innovation Service 10:15 SEGMENT REVIEWS PolyOne Distribution: Scott Horn Specialty Engineered Materials: Michael Garratt BREAK (10 MINUTES) SEGMENT REVIEWS (CONTINUED) Performance Products & Solutions: Don Wiseman Color, Additives & Inks: Mark Crist 11:40 Mergers & Acquisitions: Joel Rathbun 12:00 Financial Review: Brad Richardson 12:20 Conclusion/Q&A: Bob Patterson 1:00 LUNCH Bradley C.

ABS GREY 428C ABS DARK GREY PP FR 8-6 LMS-1000

MC-86538PV GREY MC-86884PP GREY PP FR 8-6 LMS-1000

PE COOL GREY 1C PC COOL GREY 1C PP FR 8-6 LMS-1000

You are advised to consult any further disclosures we make on related subjects in our reports on Form 10-Q, 8-K and 10-K that we provide to the Securities and Exchange Commission. $0.30 $0.52 Q4 2020 ORGANIC PERFORMANCE 3 Sales $922 $997 +8% Operating Income EPS $58 $80 +38% +73% • Record 4th quarter sales, adjusted operating income and adjusted EPS performance • All segments delivered year-over-year sales and operating income growth, led by consumer and healthcare end markets • Clariant Masterbatch integration synergy capture ahead of schedule: $5 million realized in 2020 ($ in millions except EPS) (1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition Q4 2020 SEGMENT PERFORMANCE 4 Sales Operating Income $100 $100 $100 $922 $100 $100 $100 $997 Distribution CAI SEM Total 2019 2020 $178 $272 $490 $191 $305 $526 SEM Distribution CAI +8% +7% +7% +12% $5 $5 $5 $58 $5 $5 $5 $80 Avient CAI SEM Total $17 $19 $40 $18 $30 $58 Distribution SEM CAI +38% +45% +58% +6% (3) (3) (1) (2) (1) Total company sales include intercompany sales eliminations (2) Total company reflects adjusted operating income and includes corporate costs (3) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition 2020 HIGHLIGHTS 5 • Completed transformational Clariant Masterbatch acquisition and created new brand name Avient • Increased pro forma adjusted EPS 11% from $1.74 to $1.93 as an essential supplier during the pandemic and due to growth in demand for consumer applications • Specialty Engineered Materials delivered record operating income on gains from composites • Achieved record free cash flow, increased dividend for 10th year in a row and delevered from 3.5x to 2.7x net debt to pro forma adjusted EBITDA • Culture is everything: Certified as a Great Place to Work® $133 $150 10% 23%8% 21% 4% 15% 2006 2020PF Healthcare Consumer Packaging Avient Portfolio Transformation 22% 59% CLARIANT MASTERBATCH: TRANSFORMATIONAL ACQUISITION Clariant MB EBITDA Growth Purchase Price Multiple 10.8 9.6 6.5 2019PF 2020PF 2020PF w/ Full Synergies • Acquisition of Clariant Masterbatch significantly expands presence in healthcare, packaging and consumer end markets • Strength of portfolio – 13% EBITDA growth as an essential supplier in COVID response and recovery • Acquisition completed on July 1, 2020 for $1.4 billion. We will deliver for our stakeholders through multiple value creation levers—many of which are unique to Avient: o Demand for sustainable solutions, healthcare, and composites, together with Clariant Masterbatch revenue synergies, that will drive 2021 revenue growth of 8% and long-term growth in excess of GDP o Clariant Masterbatch cost synergy capture will result in significant near-term benefit In addition, we remain committed to increasing annual dividends in line with earnings growth and opportunistically buying back shares, all while remaining modestly levered.